Focused Wealth Management’s T2 Biosystems, Inc TTOO Stock Holding History

Focused Wealth Management’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3	Closed	-$19	–	1043
2023 Q4	$19	Hold	3	–	–	﹤0.01%	1006
2023 Q3	$74	Hold	3	–	–	﹤0.01%	998
2023 Q2	$24	Hold	3	–	–	﹤0.01%	1046
2023 Q1	$155	Hold	3	–	–	﹤0.01%	990
2022 Q4	$479	Hold	3	–	–	﹤0.01%	951
2022 Q3	$2K	Hold	3	–	–	﹤0.01%	793
2022 Q2	$3K	Hold	3	–	–	﹤0.01%	712
2022 Q1	$9K	Hold	3	–	–	﹤0.01%	572
2021 Q4	$9K	Hold	3	–	–	﹤0.01%	615
2021 Q3	$15K	Hold	3	–	–	﹤0.01%	557
2021 Q2	$20K	Hold	3	–	–	﹤0.01%	514
2021 Q1	$27K	Hold	3	–	–	﹤0.01%	459
2020 Q4	$21K	Sell	3 -4	-57%	-$24.5K	﹤0.01%	459
2020 Q3	$50K	Hold	7	–	–	0.01%	320
2020 Q2	$46K	Hold	7	–	–	0.01%	315
2020 Q1	$21K	Hold	7	–	–	0.01%	371
2019 Q4	$39K	Sell	7 -1	-13%	-$9.45K	0.01%	340
2019 Q3	$101K	Buy	8 +2	+33%	+$16.1K	0.03%	232
2019 Q2	$51K	Hold	6	–	–	0.01%	320
2019 Q1	$80K	Buy	6 +2	+50%	+$34K	0.02%	246
2018 Q4	$62K	Hold	4	–	–	0.02%	282
2018 Q3	$153K	Buy	+4	New	+$132K	0.05%	182

Other funds holding TTOO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Focused Wealth Management's TTOO Position: Q1 2024 in Review

Focused Wealth Management sold out of T2 Biosystems, Inc (TTOO) in Q1 2024, closing a stake of 3 shares — an estimated $19 sold.

Focused Wealth Management first reported a position in TTOO in Q3 2018 and held it in 22 quarters. The position peaked at $153K in Q3 2018. 19 funds tracked by Wall St. Rank hold TTOO as of Q1 2024.

Focused Wealth Management reported no remaining T2 Biosystems, Inc position as of Q1 2024 after selling out during the quarter.
Focused Wealth Management sold 3 T2 Biosystems, Inc shares in Q1 2024, an estimated $19.
Focused Wealth Management first reported a position in T2 Biosystems, Inc in Q3 2018 and held it in 22 quarters.
Focused Wealth Management's T2 Biosystems, Inc position peaked at $153K in Q3 2018.
19 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.